114 related articles for article (PubMed ID: 182421)
1. Adenine arabinoside (ARA-A) blocked HSV-2 infected human skin fibroblasts as targets for the detection of serum mediated and cellular cytotoxicity in patients with cervical carcinoma.
Paulileinikki ES; Vesterinen E
Clin Exp Immunol; 1976 Aug; 25(2):264-9. PubMed ID: 182421
[TBL] [Abstract][Full Text] [Related]
2. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.
Lausch RN; Jones C; Christie D; Hay KA; Rapp F
J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859
[TBL] [Abstract][Full Text] [Related]
3. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
7. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
8. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
9. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
Thankamani V; Kumari TV; Vasudevan DM
J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
[TBL] [Abstract][Full Text] [Related]
10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
11. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
12. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
[TBL] [Abstract][Full Text] [Related]
14. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
[TBL] [Abstract][Full Text] [Related]
15. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
17. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
18. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
Clancy R; Rawls WE; Jagannath S
J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
[TBL] [Abstract][Full Text] [Related]
19. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
20. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
Perrin LH; Tishon A; Oldstone MB
J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
